MedPath

Effect of Clinical Crown Lengthening Surgery and Botulinum Toxin A Injection in Gummy Smile Treatment

Phase 4
Completed
Conditions
Gummy Smile
Interventions
Procedure: Clinical crown lengthening surgery
Registration Number
NCT05057286
Lead Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Brief Summary

Background: The demand for beauty is increasing in society as everyone is looking for cosmetic improvement, including gummy smile correction.

Object: This study aims to evaluate the efficacy of a combination of a clinical tooth crowns lengthening surgery following by a BTX-A injection in gummy smile treatment upon based on clinical assessment and photography

Method: An uncontrolled longitudinal study was implemented at the Faculty of Odonto-Stomatology (FOS) of the University of Medicine and Pharmacy at Ho Chi Minh City (UMPH), Viet Nam, from August 2020 to May 2021. Twenty patients (19 females and one male) at a mean age of 24 years old who came for gummy smile chief complaint were included in the study. Subjects were operated to lengthen the clinical crown following an additional botulinum toxin A injection two months post-surgery. All the participants answered the smile esthetic satisfactory questions and were photographed at the time before treatment (T0), two months after clinical crown lengthening surgery (T1), two weeks (T2), and two months (T3) follow-up visits after BTX-A injection. The gingival exposure (GE) and clinical crown length (CCL) were measured at each time point for analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Gummy smile because of 2 combined etiologies:

    • Short clinical crown of teeth due to the altered passive tooth eruption
    • Hyperactivity of upper lip muscles (lip mobility level > 8mm)
Exclusion Criteria
  • Pregnant or breastfeeding patients

  • Gummy smiles due to:

    • Maxillary bone overgrowth (maxillary hypertrophy)
    • Vertical maxillary excess
    • Neuromuscular disorder
    • Gingival hyperplasia due to medicine, supplements, or neuromuscular transmission inhibiting agents
  • Systematic diseases that can affect the result of surgical treatment (such as diabetes, heart disease taking blood anticoagulant medicament, blood diseases, immunodeficiency disease etc.)

  • Allergy to BTX-A or albumin

  • History of taking BTX-A injection in the head-neck area formerly

  • Patient with any contraindication of surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Subjects with gummy smileClinical crown lengthening surgeryThe study procedure consisted of recruitment, pre\&post-operative photography, gingivoplasty, BTX-A injection, recall visits, and data collecting.
Primary Outcome Measures
NameTimeMethod
Clinical crown lengthTwo months after Botulinum toxin A injection (T2)

The clinical crown length is measured in millimeters using digital caliper and periodontal probe

Gingival exposureTwo months after Botulinum toxin A injection (T2)

The outcome is measured in millimeters based on photos of subjects included

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Odontostomatology - University of Medicine and Pharmacy at Ho Chi Minh City

🇻🇳

Ho Chi Minh City, Vietnam

© Copyright 2025. All Rights Reserved by MedPath